

Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Vietstar Biomedical Research | Thai Binh University of Medicine and Pharmacy
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)
Details : Bacillus Subtilis is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Inflammatory Bowel Diseases.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
October 15, 2024
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Vietstar Biomedical Research | Thai Binh University of Medicine and Pharmacy
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Helse Stavanger | ADM Protexin
Deal Size : Inapplicable
Deal Type : Inapplicable
Bacillus Subtilis in Parkinson's Disease
Details : Bacillus Subtilis is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Parkinson Disease.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
July 05, 2024
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Helse Stavanger | ADM Protexin
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Anabio R&D
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Bacillus Subtilis is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Respiratory Tract Infections.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
July 03, 2023
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Anabio R&D
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Thai Binh University of Medicine and Pharmacy
Deal Size : Inapplicable
Deal Type : Inapplicable
LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media
Details : Bacillus Subtilis is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Respiratory Tract Infections.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 07, 2023
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Thai Binh University of Medicine and Pharmacy
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Middle East Cell and Gene Therapy | National Institute of Genetic Engineering and Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable
COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores
Details : Bacillus Subtilis is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
February 15, 2022
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Middle East Cell and Gene Therapy | National Institute of Genetic Engineering and Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores
Details : Bacillus Subtilis is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
September 27, 2021
Lead Product(s) : Bacillus Subtilis
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
